Connect with us

Cannabis

Taking a Bite Out of Unemployment, OurCrowd Portfolio Companies Need 350 Employees

Even as the coronavirus pandemic rages, startups are offering hundreds of new jobs. The number of vacant positions at OurCrowd’s portfolio companies has risen to 350, with 90 new job vacancies added since the start of April, 41 of them in Israel. Despite Israel’s unprecedented unemployment situation, high-tech companies are still recruiting. Now that Israel […]

The post Taking a Bite Out of Unemployment, OurCrowd Portfolio Companies Need 350 Employees appeared first on OurCrowd.

Published

on

Even as the coronavirus pandemic rages, startups are offering hundreds of new jobs. The number of vacant positions at OurCrowd’s portfolio companies has risen to 350, with 90 new job vacancies added since the start of April, 41 of them in Israel.

Despite Israel’s unprecedented unemployment situation, high-tech companies are still recruiting. Now that Israel has gone back to work on the downside of the virus curve, entrepreneurs and startups have a huge role to play in getting our nation back to work.

OurTalent, OurCrowd’s jobs portal, currently lists 350 vacant positions from within its portfolio companies, with fresh opportunities added each week. The top recruiting companies include SixGill, BioCatch, and Locusview.

OurCrowd portfolio companies offer work in Israel and around the world. There are vacancies listed in Jerusalem, Tel Aviv and other Israeli locations, but also positions across the globe including New York, Toronto, California, Brazil and Barcelona.

Positions advertised on OurTalent are continuously updated as a service to our companies. Applicants are invited to contact the companies directly.

While global tech giants like Uber, Lyft and Airbnb are laying off staff, other startups are providing solutions people need while they are working from home and social distancing, which means many OurCrowd companies are actually expanding quicker than they originally planned.

“Even in these tough times, your dream job could be waiting at the Startup Nation’s next billion-dollar unicorn. Startups of all sizes are looking for a range of talent, from bookkeepers to illustrators to full-stack engineers,” says Laly David, OurCrowd Partner and head of Business Development.

SixGill, a company based in Netanya, is a cyber-intelligence company that analyses and monitors the deep web and dark web, providing threat intelligence for businesses against hackers and cyber-attacks. Demand for its services has grown as cyber-criminals use the pandemic crisis as cover to increase their attacks.

“SixGill is in an unprecedented momentum of growth,” says Hadar Hen, SixGill’s human resources director. “We recently closed a fundraising round and we now see it as our national duty to grow out of the crisis and set an example. As cyber intelligence technology leaders, we are looking for talents that will allow us to move on to the next stage of the field’s evolution.”

For its technical teams, SixGill is looking for people with deep knowledge of cutting-edge technology.

“We are looking for individuals with a passion for innovation and specialization in a range of leading technologies today,” Hen says. “For those looking for jobs, I would advise taking the time to acquire capabilities, especially in the fields of artificial intelligence and big data as well as polishing your resume and social profiles, and generally working on your brand to be prepared for the day after.

But the company is also looking to fill more traditional roles. It is currently searching for a full-time controller for its accounting and finance department.

LocusView is an Israeli-American tech company providing a digital platform that collects, validates, and manages new construction data for energy infrastructure.

“Our goal at Locusview is to help energy utilities build a safer world and prepare for the coming challenges of building smarter energy infrastructure,” says Rony Kaufman, the company’s Human Resources Manager. “This is a long-distance goal that isn’t removed by COVID19 or its implications. In this sense, we were lucky enough to be part of an essential industry. When COVID19 started we realized that we must give our team as much certainty as possible. We didn’t do any pay cuts and didn’t lay off any of our staff.  We understand that now is the time to find the people who want to be part of a team that continues to grow even in times of uncertainty.”

Comments

comments

Source: https://blog.ourcrowd.com/taking-a-bite-out-of-unemployment-ourcrowd-portfolio-companies-need-350-employees/

Cannabis

Fort Collins cannabis equipment firm sues California manufacturer

Published

on

FORT COLLINS — A local maker of cannabinoid compound separators is suing a duo of California companies over allegedly failing to pay almost $110,000 for industrial cannabis equipment.

In the complaint filed Friday in the U.S. District Court of Colorado, Fort Collins-based Illuminated Extractors Ltd. claims that it was hired last year to provide equipment and consulting services for sister firms NT Ventures Inc. and ANP Holdings Inc., which do business as cannabis product manufacturer NewTropic.

The extraction machines in question use hydrocarbon compounds such as propane and butane to strip CBD and other oils from marijuana and hemp plants. Those separated cannabinoids are then used in marijuana and CBD products.

In particular, Illuminated said it built and sold the companies an industrial-scale cannabinoid extractor for $673,400, but it has yet to be paid $78,539 for the remainder of the deal. The Fort Collins company also alleges tha it is owed $31,443 in unpaid lease and fees for a different piece of extraction equipment.

NewTropic did not respond to a request for comment Tuesday.

© 2020 BizWest Media LLC

FORT COLLINS — A local maker of cannabinoid compound separators is suing a duo of California companies over allegedly failing to pay almost $110,000 for industrial cannabis equipment.

In the complaint filed Friday in the U.S. District Court of Colorado, Fort Collins-based Illuminated Extractors Ltd. claims that it was hired last year to provide equipment and consulting services for sister firms NT Ventures Inc. and ANP Holdings Inc., which do business as cannabis product manufacturer NewTropic.

The extraction machines in question use hydrocarbon compounds such as propane and butane to strip CBD and other oils from marijuana and hemp plants. Those separated cannabinoids are then used in marijuana and CBD products.

In particular, Illuminated said it built and sold the companies an industrial-scale cannabinoid extractor for $673,400, but it has yet to be paid $78,539 for the remainder of the deal. The Fort Collins company also alleges tha it is owed $31,443 in unpaid lease and fees for a different piece of extraction equipment.

NewTropic did not respond to a request for comment Tuesday.

© 2020 BizWest Media LLC

Original Author Link click here to read complete story..

Source: https://mmpconnect.com/fort-collins-cannabis-equipment-firm-sues-california-manufacturer/

Continue Reading

Cannabis

Fort Collins cannabis equipment firm sues California manufacturer

Published

on

FORT COLLINS — A local maker of cannabinoid compound separators is suing a duo of California companies over allegedly failing to pay almost $110,000 for industrial cannabis equipment.

In the complaint filed Friday in the U.S. District Court of Colorado, Fort Collins-based Illuminated Extractors Ltd. claims that it was hired last year to provide equipment and consulting services for sister firms NT Ventures Inc. and ANP Holdings Inc., which do business as cannabis product manufacturer NewTropic.

The extraction machines in question use hydrocarbon compounds such as propane and butane to strip CBD and other oils from marijuana and hemp plants. Those separated cannabinoids are then used in marijuana and CBD products.

In particular, Illuminated said it built and sold the companies an industrial-scale cannabinoid extractor for $673,400, but it has yet to be paid $78,539 for the remainder of the deal. The Fort Collins company also alleges tha it is owed $31,443 in unpaid lease and fees for a different piece of extraction equipment.

NewTropic did not respond to a request for comment Tuesday.

© 2020 BizWest Media LLC

FORT COLLINS — A local maker of cannabinoid compound separators is suing a duo of California companies over allegedly failing to pay almost $110,000 for industrial cannabis equipment.

In the complaint filed Friday in the U.S. District Court of Colorado, Fort Collins-based Illuminated Extractors Ltd. claims that it was hired last year to provide equipment and consulting services for sister firms NT Ventures Inc. and ANP Holdings Inc., which do business as cannabis product manufacturer NewTropic.

The extraction machines in question use hydrocarbon compounds such as propane and butane to strip CBD and other oils from marijuana and hemp plants. Those separated cannabinoids are then used in marijuana and CBD products.

In particular, Illuminated said it built and sold the companies an industrial-scale cannabinoid extractor for $673,400, but it has yet to be paid $78,539 for the remainder of the deal. The Fort Collins company also alleges tha it is owed $31,443 in unpaid lease and fees for a different piece of extraction equipment.

NewTropic did not respond to a request for comment Tuesday.

© 2020 BizWest Media LLC

Original Author Link click here to read complete story..

Source: https://mmpconnect.com/fort-collins-cannabis-equipment-firm-sues-california-manufacturer/

Continue Reading

Cannabis

British newborn first baby in world to join cannabis therapy trial

Published

on

A newborn boy who was delivered by emergency caesarean section in March at a Norwich hospital became the first baby in the world to join a cannabis-derived treatment trial.

The study is the first step in what researchers say could one day lead to a cannabis-derived medicine being used routinely in neonatal care to help babies at risk of seizures and brain injury.

The baby, Oscar Parodi, was delivered on 11 March at Norfolk and Norwich university hospital (NNUH). He was unexpectedly born in a poor condition and needed to be transferred to the neonatal intensive care unit, where he had cooling therapy for 72 hours.

His mother, Chelsea Parodi, from Watton, Norfolk, said: “I was approached after the birth about taking part in this study and I consulted my mum and my brother who is training to be a paramedic. It was hard but I wanted to do everything I could to help my baby boy. Oscar was in hospital for nine days and he was being monitored 24/7.” Parodi said her son was “doing fantastically well”.

The study is examining whether the medicine is safe and effective in lessening the degree of brain injury for babies with the condition neonatal hypoxic ischemic encephalopathy (HIE).

Prof Paul Clarke, a consultant neonatologist at NNUH, said there was a lot of excitement at the neonatal intensive care unit. “This is the first time a cannabis-derived medicine has been tested intravenously in human babies. It is hoped that it will be good for preventing seizures and protecting the brains of newborn babies with HIE.

“We have always had good support from families wanting to take part in research on our [unit] and they often do it from an altruistic point of view to help benefit future babies. One of the attractions of this trial for parents is the closer brain monitoring babies get as part of the study, because a more advanced brainwave monitor is used for the trial babies. This gives parents more reassurance that any seizures will be picked up.”

A second child, born in April at the hospital, is also part of the trial. Children in the trial receive standard hypothermia treatment for HIE, where the whole body is cooled down to 33.5C, as well as a single dose of the study drug or placebo, followed by some tests to measure levels of the drug in the blood.

The trial, in which the drug is administered intravenously and in which the first babies to take part only receive a 30th of the usual dose, involves other neonatal intensive care units in the UK and elsewhere in Europe and will take a year to complete.

Babies in the trial will be given a single dose of study medication, or a placebo, as soon as possible within 12 hours of birth.

The therapeutic ingredient of the medicine occurs naturally in the cannabis plant and is extracted under highly controlled conditions to ensure that the tetrahydrocannabinol (THC) component which causes a “high” is minimal.

Clarke added: “As with any study of a new medicine there may be unexpected side effects…

Source: https://mmpconnect.com/british-newborn-first-baby-in-world-to-join-cannabis-therapy-trial/

Continue Reading

Trending